Annual EBIT
-$6.86 M
-$4.54 M-196.02%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual earnings before interest & taxes is -$6.86 million, with the most recent change of -$4.54 million (-196.02%) on December 31, 2023.
- During the last 3 years, CHRO annual EBIT has fallen by -$6.20 million (-941.48%).
- CHRO annual EBIT is now -1053.13% below its all-time high of -$595.10 thousand, reached on December 1, 2021.
Performance
CHRO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.66 M
+$104.92 K+5.96%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly earnings before interest & taxes is -$1.66 million, with the most recent change of +$104.92 thousand (+5.96%) on September 30, 2024.
- Over the past year, CHRO quarterly EBIT has increased by +$2.22 million (+57.32%).
- CHRO quarterly EBIT is now -688.40% below its all-time high of -$210.00 thousand, reached on December 1, 2021.
Performance
CHRO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$9.23 M
-$363.94 K-4.11%
September 30, 2024
Summary
- As of February 7, 2025, CHRO TTM earnings before interest & taxes is -$9.23 million, with the most recent change of -$363.94 thousand (-4.11%) on September 30, 2024.
- Over the past year, CHRO TTM EBIT has dropped by -$2.37 million (-34.49%).
- CHRO TTM EBIT is now -4294.76% below its all-time high of -$210.00 thousand, reached on December 1, 2021.
Performance
CHRO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CHRO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -196.0% | +57.3% | -34.5% |
| 3 y3 years | -941.5% | -219.1% | -602.7% |
| 5 y5 years | -941.5% | -219.1% | -602.7% |
CHRO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1053.1% | at low | -688.4% | +57.3% | -4294.8% | at low |
| 5 y | 5-year | -1053.1% | at low | -688.4% | +57.3% | -4294.8% | at low |
| alltime | all time | -1053.1% | at low | -688.4% | +57.3% | -4294.8% | at low |
Chromocell Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.66 M(-6.0%) | -$9.23 M(+4.1%) |
| Jun 2024 | - | -$1.76 M(-9.0%) | -$8.87 M(+12.5%) |
| Mar 2024 | - | -$1.93 M(-50.1%) | -$7.88 M(+14.9%) |
| Dec 2023 | -$6.86 M | -$3.88 M(+200.3%) | -$6.86 M(+63.5%) |
| Sep 2023 | - | -$1.29 M(+66.2%) | -$4.20 M(+22.6%) |
| Jun 2023 | - | -$777.20 K(-15.0%) | -$3.43 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$914.60 K(-24.7%) | -$2.94 M(+27.0%) |
| Dec 2022 | -$2.32 M(+289.5%) | -$1.21 M(+134.2%) | -$2.32 M(+76.5%) |
| Sep 2022 | - | -$518.80 K(+74.9%) | -$1.31 M(+65.3%) |
| Jun 2022 | - | -$296.70 K(+3.1%) | -$794.50 K(+59.6%) |
| Mar 2022 | - | -$287.80 K(+37.0%) | -$497.80 K(+137.0%) |
| Dec 2021 | -$595.10 K(-9.7%) | -$210.00 K | -$210.00 K |
| Dec 2020 | -$658.90 K | - | - |
FAQ
- What is Chromocell Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual EBIT year-on-year change?
- What is Chromocell Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly EBIT year-on-year change?
- What is Chromocell Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Chromocell Therapeutics?
- What is Chromocell Therapeutics TTM EBIT year-on-year change?
What is Chromocell Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CHRO is -$6.86 M
What is the all time high annual EBIT for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual earnings before interest & taxes is -$595.10 K
What is Chromocell Therapeutics annual EBIT year-on-year change?
Over the past year, CHRO annual earnings before interest & taxes has changed by -$4.54 M (-196.02%)
What is Chromocell Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CHRO is -$1.66 M
What is the all time high quarterly EBIT for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly earnings before interest & taxes is -$210.00 K
What is Chromocell Therapeutics quarterly EBIT year-on-year change?
Over the past year, CHRO quarterly earnings before interest & taxes has changed by +$2.22 M (+57.32%)
What is Chromocell Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CHRO is -$9.23 M
What is the all time high TTM EBIT for Chromocell Therapeutics?
Chromocell Therapeutics all-time high TTM earnings before interest & taxes is -$210.00 K
What is Chromocell Therapeutics TTM EBIT year-on-year change?
Over the past year, CHRO TTM earnings before interest & taxes has changed by -$2.37 M (-34.49%)